ROLE OF HERBAL FORMULATION OF GARLIC ON LIPID PROFILE IN PATIENTS WITH TYPE 2 DIABETES RELATED DYSLIPIDEMIA

被引:0
|
作者
Siddiqui, Naveed Ali [1 ]
Haider, Saida [1 ]
Misbah-ur-Rehman, Mohammad [2 ]
Perveen, Tahira [1 ]
机构
[1] Univ Karachi, Dept Biochem, Karachi, Pakistan
[2] Jinnah Sindh Med Univ, Karachi, Pakistan
来源
PAKISTAN HEART JOURNAL | 2016年 / 49卷 / 04期
关键词
Lipid profile; dyslipidemia; herbal product; garlic;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate the role and side effects of garlic on lipid profile in diabetic dyslipidemic patients along with their lipid lowering efficacy. Methodology: This cross sectional study was carried out at Surgeon Munawar Memorial Hospital Bahadurabad Karachi. The study period consisted of 8 weeks st st from 1 February 2015 to 31 March 2015. Patients with age between 30 and 60 years of either gender with diabetic dyslipidemia were included. The exclusion criteria included pregnant/lactating females, liver, renal and established coronary artery disease or ischemic heart disease. Results: Total of 30 diabetic dyslipidemic patients with abnormal lipid profile were included. Patients were orally administered with local herbal product of garlic (300 mg/day) for 8 weeks. Serum levels of cholesterol, high density lipoprotein (HDL), triglyceride (TG), and low density lipoprotein (LDL) were estimated in patients before and after treatment with local herbal product of garlic (300 mg/day). After the treatment of garlic, serum cholesterol and low density lipoprotein were significantly decreased but there was no effect on triglyceride levels (p > 0.05). Conclusion: On the basis of this study we concluded that herbal products like garlic significantly decreases cholesterol, low density lipoprotein (LDL) and increases high density lipoprotein (HDL).
引用
收藏
页码:146 / 150
页数:5
相关论文
共 50 条
  • [1] Prevalence of dyslipidemia and factors affecting lipid profile in patients with type 2 diabetes
    Shahwan, Moyad Jamal
    Jairoun, Ammar Abdulrahman
    Farajallah, Alaa
    Shanabli, Sawsan
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (04) : 2387 - 2392
  • [2] Effects of policosanol and lovastatin on lipid profile-and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus
    Castaño, G
    Menéndez, R
    Más, R
    Amor, A
    Fernández, JL
    González, RL
    Lezcay, M
    Alvarez, E
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2002, 22 (3-4) : 89 - 99
  • [3] Postprandial lipid profile in patients with type 2 diabetes
    Katsiki, Niki
    Kolovou, Genovefa
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (01) : 121 - 121
  • [4] Lipid Profile and Prevalence of Dyslipidemia in Type 1 Diabetes Adults in Spain
    Rodriguez Carnero, Maria Gemma
    Bellido Guerrero, Diego, Sr.
    Tejera, Cristina
    Lopez De la Torre, Martin
    Soto Gonzalez, Alfonso, Sr.
    Escalada, Francisco J.
    Hernandez-Mijares, Antonio, Sr.
    Suarez Gutierrez, Lorena, Sr.
    Morales, Cristobal, Sr.
    Gutierrez Carrasqu, Liliana, Sr.
    Cadenas, Aida
    Diaz Trastoy, Olaia
    Amigo-Farran, Judit
    Gonzalez Molero, Inma
    Bellido, Virginia
    Arrieta, Francisco
    Tinahones, Francisco
    [J]. DIABETES, 2019, 68
  • [5] THE ROLE OF A NEW FORMULATION OF FENOFIBRIC ACID IN THE TREATMENT OF MIXED DYSLIPIDEMIA IN TYPE 2 DIABETES
    Campbell, J.
    Mohiuddin, S. M.
    [J]. DRUGS OF TODAY, 2010, 46 (10) : 757 - 764
  • [6] NEW INSIGHTS INTO STATIN ACTION ON THE DYSLIPIDEMIA OF TYPE 2 DIABETES: NORMALISATION OF THE PLASMA LIPID PROFILE
    Meikle, P. J.
    Wong, G.
    Tan, R.
    Kingwell, B. A.
    Orsoni, A.
    Hounslow, N.
    Giral, P.
    Chapman, M. J.
    [J]. ATHEROSCLEROSIS, 2014, 235 (02) : E106 - E107
  • [7] INSULIN THERAPY AND LIPID PROFILE IN PATIENTS WITH TYPE 2 DIABETES
    Lazzari, P.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 75 - 75
  • [8] The effect of pioglitazone on the lipid profile in patients with type 2 diabetes
    Shaffer, S
    Rubin, CJ
    Zhu, E
    [J]. DIABETES, 2000, 49 : A125 - A125
  • [9] The influence of fenofibrate on lipid profile, endothelial dysfunction, and inflammatory markers in type 2 diabetes mellitus patients with typical and mixed dyslipidemia
    Ghani, Rohana Abdul
    Bin Yaakob, Ismail
    Wahab, Norasyikin Abdul
    Zainudin, Suehazlyn
    Mustafa, Norlaila
    Sukor, Norlela
    Mohamud, Wan Nazaimoon Wan
    Kadir, Khalid Abdul
    Kamaruddin, Nor Azmi
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2013, 7 (05) : 446 - 453
  • [10] A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia
    Goldberg, RB
    Kendall, DM
    Deeg, MA
    Buse, JB
    Zagar, AJ
    Pinaire, JA
    Tan, MH
    Khan, MA
    Perez, AT
    Jacober, SJ
    [J]. CIRCULATION, 2005, 111 (13) : 1727 - 1728